R. Chlebowski, S. Hendrix, R. Langer, M. Stefanick, M. Gass et al., Influence of Estrogen Plus Progestin on Breast Cancer and Mammography in Healthy Postmenopausal Women, JAMA, vol.289, issue.24, pp.3243-53, 2003.
DOI : 10.1001/jama.289.24.3243

A. Hersh, M. Stefanick, and R. Stafford, National Use of Postmenopausal Hormone Therapy, JAMA, vol.291, issue.1, pp.47-53, 2004.
DOI : 10.1001/jama.291.1.47

F. Clavel-chapelon and E. Group, Differential effects of reproductive factors on the risk of pre-and post-menopausal breast cancer. Results from a large cohort of French women, Br J Cancer, vol.4, pp.723-730, 2002.

E. Riboli, Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC), Annals of Oncology, vol.3, issue.10, pp.783-91, 1992.
DOI : 10.1093/oxfordjournals.annonc.a058097

R. Ross, A. Paganini-hill, P. Wan, and M. Pike, Effect of Hormone Replacement Therapy on Breast Cancer Risk: Estrogen Versus Estrogen Plus Progestin, Journal of the National Cancer Institute, vol.92, issue.4, pp.328-360, 2000.
DOI : 10.1093/jnci/92.4.328

C. Schairer, J. Lubin, R. Troisi, S. Sturgeon, L. Brinton et al., Menopausal Estrogen and Estrogen-Progestin Replacement Therapy and Breast Cancer Risk, JAMA, vol.283, issue.4, pp.485-91, 2000.
DOI : 10.1001/jama.283.4.485

J. Porch, I. Lee, N. Cook, K. Rexrode, and J. Buring, Estrogen-progestin replacement therapy and breast cancer risk: the Women's Health Study (United States), Cancer Causes and Control, vol.13, issue.9, pp.847-54, 2002.
DOI : 10.1023/A:1020617415381

L. Weiss, R. Burkman, K. Cushing-haugen, L. Voigt, M. Simon et al., Hormone Replacement Therapy Regimens and Breast Cancer Risk, Obstetrics & Gynecology, vol.100, issue.6, pp.1148-58, 2002.
DOI : 10.1097/00006250-200212000-00003

C. Li, K. Malone, P. Porter, N. Weiss, M. Tang et al., Relationship Between Long Durations and Different Regimens of Hormone Therapy and Risk of Breast Cancer, JAMA, vol.289, issue.24, pp.3254-63, 2003.
DOI : 10.1001/jama.289.24.3254

C. Magnusson, J. Baron, N. Correia, R. Bergstrom, H. Adami et al., Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy, International Journal of Cancer, vol.4, issue.3, pp.339-383, 1999.
DOI : 10.1002/(SICI)1097-0215(19990505)81:3<339::AID-IJC5>3.0.CO;2-6

I. Persson, E. Weiderpass, L. Bergkvist, R. Bergstrom, and C. Schairer, Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement, Cancer Causes and Control, vol.10, issue.4, pp.253-60, 1999.
DOI : 10.1023/A:1008909128110

H. Olsson, C. Ingvar, and A. Bladstrom, Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden, Cancer, vol.336, issue.6, pp.1387-92, 2003.
DOI : 10.1002/cncr.11205

H. Jernstrom, P. Bendahl, J. Lidfeldt, C. Nerbrand, C. Agardh et al., A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden), Cancer Causes and Control, vol.14, issue.7, pp.673-680, 2003.
DOI : 10.1023/A:1025635720208

C. Stahlberg, A. Pedersen, E. Lynge, Z. Andersen, N. Keiding et al., Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe, International Journal of Cancer, vol.76, issue.5, pp.721-727, 2004.
DOI : 10.1002/ijc.20016

T. Key and M. Pike, The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer, European Journal of Cancer and Clinical Oncology, vol.24, issue.1
DOI : 10.1016/0277-5379(88)90173-3

D. Fergusson and T. Anderson, Morphological evaluation of cell turnover in relation to the menstrual cycle in the ???resting??? human breast, British Journal of Cancer, vol.44, issue.2, pp.177-81, 1981.
DOI : 10.1038/bjc.1981.168

J. Going, T. Anderson, S. Battersby, and C. Macintyre, Proliferative and secretory activity in human breast during natural and artificial menstrual cycles, Am J Pathol, vol.130, pp.193-204, 1988.

C. Potten, R. Watson, G. Williams, S. Tickle, S. Roberts et al., The effect of age and menstrual cycle upon proliferative activity of the normal human breast, British Journal of Cancer, vol.58, issue.2, pp.163-70, 1988.
DOI : 10.1038/bjc.1988.185

M. Mcmanus and C. Welsch, The effect of estrogen, progesterone, thyroxine, and human placental lactogen on DNA synthesis of human breast ductal epithelium maintained in athymic nude mice, Cancer, vol.39, issue.9, pp.1920-1927, 1984.
DOI : 10.1002/1097-0142(19841101)54:9<1920::AID-CNCR2820540924>3.0.CO;2-F

K. Chang, S. Fournier, L. Ti, T. De-lignières, B. Linares et al., Influences of percutaneous administration of estradiol and progesterone on human breast epithelial cell cycle in vivo**Supported by Besins-Iscovesco, Paris, France and Orient Europharma, Taipei, Taiwan.??????Presented in part at the 7th International Congress on the Menopause, Stockholm, Sweden, June 20 to 24, 1993., Fertility and Sterility, vol.63, issue.4, pp.785-91, 1995.
DOI : 10.1016/S0015-0282(16)57482-2

J. Foidart, C. Colin, X. Denoo, J. Desreux, A. Beliard et al., Estradiol and Progesterone Regulate the Proliferation of Human Breast Epithelial Cells, Fertility and Sterility, vol.69, issue.5, pp.963-972, 1998.
DOI : 10.1016/S0015-0282(98)00042-9

G. Greendale, B. Reboussin, S. Slone, C. Wasilauskas, M. Pike et al., Postmenopausal Hormone Therapy and Change in Mammographic Density, JNCI Journal of the National Cancer Institute, vol.95, issue.1, pp.30-37, 2003.
DOI : 10.1093/jnci/95.1.30

G. Colditz, S. Hankinson, D. Hunter, W. Willett, J. Manson et al., The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women, New England Journal of Medicine, vol.332, issue.24, pp.1589-93, 1995.
DOI : 10.1056/NEJM199506153322401

I. Persson, E. Thurfjell, R. Bergström, and L. Holmberg, Hormone replacement therapy and the risk of breast cancer. Nested case-control study in a cohort of Swedish women attending mammography screening, International Journal of Cancer, vol.3, issue.5, pp.758-61, 1997.
DOI : 10.1002/(SICI)1097-0215(19970904)72:5<758::AID-IJC9>3.0.CO;2-R

C. Chen, N. Weiss, P. Newcomb, W. Barlow, and E. White, Hormone Replacement Therapy in Relation to Breast Cancer, JAMA, vol.287, issue.6, pp.734-775, 2002.
DOI : 10.1001/jama.287.6.734

C. Campagnoli, S. Ambroggio, N. Biglia, and P. Sismondi, Conjugated estrogens and breast cancer risk, Gynecol Endocrinol, vol.13, issue.6, pp.13-22, 1999.

C. Campagnoli, N. Biglia, C. Peris, and P. Sismondi, Potential impact on breast cancer risk of circulating insulin???like growth factor I modifications induced by oral HRT in menopause, Gynecological Endocrinology, vol.52, issue.1, pp.67-74, 1995.
DOI : 10.1210/edrv-11-2-266

M. Bellantoni, J. Vittone, A. Campfield, K. Bass, S. Harman et al., Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study, J Clin Endocrinol Metabol, vol.81, pp.2848-53, 1996.

S. Hankinson, W. Willett, G. Colditz, D. Hunter, D. Michaud et al., Circulating concentrations of insulin-like growth factor I and risk of breast cancer, The Lancet, vol.351, issue.9113, pp.1393-1399, 1998.
DOI : 10.1016/S0140-6736(97)10384-1

A. Jacquotte, Serum insulin-like growth factor-I and breast cancer, Int J Cancer, vol.88, pp.828-860, 2000.

P. Muti, T. Quattrin, B. Grant, V. Krogh, A. Micheli et al., Fasting glucose is a risk factor for breast cancer: a prospective study, Cancer Epidemiol Biomarkers Prev, vol.11, pp.1361-1369, 2002.

M. Haftenberger, P. Lahmann, S. Panico, C. Gonzalez, J. Seidell et al., Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC), Public Health Nutrition, vol.288, issue.6b, pp.1147-62, 2002.
DOI : 10.1093/ije/26.suppl_1.S6

M. Pike, R. Ross, and D. Spicer, Problems Involved in Including Women with Simple Hysterectomy in Epidemiologic Studies Measuring the Effects of Hormone Replacement Therapy on Breast Cancer Risk, American Journal of Epidemiology, vol.147, issue.8, pp.718-721, 1998.
DOI : 10.1093/oxfordjournals.aje.a009515

B. Rockhill, G. Colditz, and B. Rosner, Bias in Breast Cancer Analyses Due to Error in Age at Menopause, American Journal of Epidemiology, vol.151, issue.4, pp.404-408, 2000.
DOI : 10.1093/oxfordjournals.aje.a010220

E. Banks, Hormone replacement therapy and the sensitivity and specificity of breast cancer screening: a review, Journal of Medical Screening, vol.8, issue.1, pp.29-34, 2001.
DOI : 10.1136/jms.8.1.29

B. Séradour, J. Estève, P. Heid, and J. Jacquemier, Hormone replacement therapy and screening mammography: analysis of the results in the Bouches du Rhone programme, Journal of Medical Screening, vol.6, issue.2, pp.99-102, 1999.
DOI : 10.1136/jms.6.2.99